The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease

Wiener Klinische Wochenschrift

Volumn 124, Issue 15-16, 2012, Pages 526-531

  Purnak, Tugrul ^a   Beyazit, Yavuz ^b   Ozaslan, Ersan ^a   Efe, Cumali ^a   Hayretci, Merve ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Yuksek Ihtisas Education and Research Hospital   (Turkey)

Author keywords

Bone mass; Liver function tests; Metabolic syndrome; Obesity; Osteopenia; Simple steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FATTY LIVER; FEMALE; HUMAN; LABORATORY TEST; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RISK FACTOR;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; FATTY LIVER; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866239792     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-012-0211-4     Document Type: Article

References (33)

1. Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol. 2007;17:863-9. (Pubitemid 47588954)
2. Duvnjak M, Lerotic I, Barsic N, et al. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol. 2007;13:4539-50. (Pubitemid 47455230)
3. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology 2009;49:306-17.
4. Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005;42:650-6. (Pubitemid 41233658)
5. Kogiso T, Moriyoshi Y, Shimizu S, Nagahara H, Shiratori K. High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the akaike Information criterion scoring system in the general Japanese population. J Gastroenterol. 2009;44:313-21.
6. Kinjo M, Setoguchi S, Solomon DH. Bone mineral density in adults with the metabolic syndrome: Analysis in a population-based US sample. J Clin Endocrinol Metab. 2007;92:4161-4. (Pubitemid 350074726)
7. Kelman A, Lane NE. The management of secondary osteoporosis. Best Pract Res Clin Rheumatol. 2005;19:1021-37. (Pubitemid 41748512)
8. Kotake S, Udagawa N, Hakoda M, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: Possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 2001;44:1003-12. (Pubitemid 32433604)
9. Smith BJ, Lerner MR, Bu SY, et al. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 2006;38:378-6. (Pubitemid 43255432)
10. Caetano-Lopes J, Canhao H, Fonseca JE. Osteoimmunology- the hidden immune regulation of bone. Autoimmun Rev. 2009;8:250-5.
11. Tilg H, Moschen AR, Kaser A, Pines A, Dotan I. Gut inflammation and osteoporosis: Basic and clinical concepts. Gut 2008;57:684-4. (Pubitemid 351579985)
12. Lacativa PG, Farias ML. Osteoporosis and inflammation. Arq Bras Endocrinol Metabol. 2010;54:123-2.
13. Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig Dis. 2010;28:179-85.
14. Ndumele CE, Nasir K, Conceicao RD, et al. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. Arterioscler Thromb Vasc Biol. 2011;31(8):1927-32.
15. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19. (Pubitemid 15018832)
16. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-10.
17. Bouillon R, Auwerx J, Dekeyser L, et al. Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab. 1984;59:86-9. (Pubitemid 14087530)
18. Skinner RK, Sherlock S, Long RG, Wilis MR. 25-Hydroxylation of vitamin D in primary biliary cirrhosis. Lancet 1977;1:720-1. (Pubitemid 8060811)
19. Nakchbandi IA, Van Der Merwe SW. Current understanding of osteoporosis associated with liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:660-70.
20. Hwang DK, Choi HJ. The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int. 2009;21(3):425-31.
21. Marchesini G, Marzocchi R. Metabolic syndrome and NASH. Clin Liver Dis. 2007;11:105-17ix. (Pubitemid 46829976)
22. Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003;125:941-66. (Pubitemid 37070710)
23. Schiefke I, Fach A, Wiedmann M, et al. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005;11:1843-7. (Pubitemid 40520782)
24. Guggenbuhl P, Deugnier Y, Boisdet JF, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int. 2005;16:1809-14. (Pubitemid 41790893)
25. Hegedus D, Ferencz V, Lakatos PL, et al. Decreased bone density, elevated serum osteoprotegerin, and beta-crosslaps in Wilson disease. J Bone Miner Res. 2002;17:1961-7. (Pubitemid 35239197)
26. Crippin JS, Jorgensen RA, Dickson ER, Lindor KD. Hepatic osteodystrophy in primary biliary cirrhosis: Effects of medical treatment. Am J Gastroenterol. 1994;89:47-50. (Pubitemid 24020051)
27. Levy C, Lindor KD. Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis. Clin Liver Dis. 2003;7:901-0. (Pubitemid 37229509)
28. Bauer DC, Sklarin PM, Stone KL, et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: The study of osteoporotic fractures. J Bone Miner Res. 1999;14:1404-0. (Pubitemid 29368303)
29. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003;124:795-41. (Pubitemid 36268496)
30. Rogers A, Hannon RA, Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res. 2000;15:1398-04. (Pubitemid 30413874)
31. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol. 2007;102:2716-7. (Pubitemid 350179334)
32. Babali A, Cakal E, Purnak T, et al. Serum alpha-fetoprotein levels in liver steatosis. Hepatol Int. 2009;3(4):551-5.
33. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708-15. (Pubitemid 350179336)